speb/financial-data huggingface dataset:
CCJ balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3542674000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7983820000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2356913000.00
CCJ income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 510114000.00
CCJ income_statement (annual, 2024-12-31) — Total Other Finance Cost: 19007000.00
CCJ balance_sheet (annual, 2024-12-31) — Total Tax Payable: 21225000.00
CCJ income_statement (annual, 2024-12-31) — Total Unusual Items: -118628000.00
CCJ income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -118628000.00
CCJ balance_sheet (annual, 2024-12-31) — Working Capital: 737426000.00
CCJ income_statement (quarterly, 2025-03-31) — +Operating Expense: 82109000.00
CCJ income_statement (quarterly, 2025-03-31) — +Total Revenue: 789432000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 346229000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 149345000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 204497000.00
CCJ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 435312000.00
CCJ income_statement (quarterly, 2025-03-31) — Basic EPS: 0.16
CCJ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 600462000.00
CCJ cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -56458000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2935465000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 361469000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 361469000.00
CCJ cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
CCJ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -291643000.00
CCJ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -57389000.00
CCJ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 110191000.00
CCJ cash_flow (quarterly, 2025-03-31) — Change In Inventory: 10157000.00
CCJ cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -287626000.00
CCJ cash_flow (quarterly, 2025-03-31) — Change In Receivables: 197316000.00
CCJ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -80153000.00
CCJ cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 197316000.00
CCJ cash_flow (quarterly, 2025-03-31) — Changes In Cash: -238841000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Common Stock: 2935465000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6491796000.00
CCJ cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 73000.00
CCJ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 519295000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Current Assets: 1500125000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 554565000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Current Provisions: 43630000.00
CCJ cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 53405000.00
CCJ cash_flow (quarterly, 2025-03-31) — Deferred Tax: 53405000.00
CCJ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 60602000.00
CCJ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 60602000.00
CCJ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 435514000.00
CCJ income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.16
CCJ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 69764000.00
CCJ cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 69747000.00
CCJ income_statement (quarterly, 2025-03-31) — EBIT: 148630000.00
CCJ income_statement (quarterly, 2025-03-31) — EBITDA: 209232000.00
CCJ income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -26850000.00
CCJ cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 26850000.00
CCJ cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -152000.00
CCJ cash_flow (quarterly, 2025-03-31) — End Cash Position: 361469000.00
CCJ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -291643000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Finished Goods: 800025000.00
CCJ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 53733000.00
CCJ cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -13013000.00
CCJ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -2217000.00
CCJ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -9799000.00
CCJ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 58820000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 39137000.00
CCJ income_statement (quarterly, 2025-03-31) — Gross Profit: 270137000.00
CCJ income_statement (quarterly, 2025-03-31) — Interest Expense: 25473000.00
CCJ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 25473000.00
CCJ income_statement (quarterly, 2025-03-31) — Interest Income: 3689000.00
CCJ income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3689000.00
CCJ cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -5883000.00
CCJ cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 3689000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Inventory: 953207000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7487540000.00
CCJ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -57389000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3181588000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 333423000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 2848165000.00
CCJ cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 73000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 0.00
CCJ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 995744000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 995744000.00
CCJ cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -285841000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3181588000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1003557000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Minority Interest: 14000.00
CCJ income_statement (quarterly, 2025-03-31) — Minority Interests: 12000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 73000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Net Debt: 634275000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 871000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income: 69764000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 69764000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 69752000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 69764000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 69764000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 69752000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 69752000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Interest Income: -26409000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -285841000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -285841000.00
CCJ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -26409000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 8000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -954000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Net PPE: 3277651000.00
CCJ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -56435000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6452659000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 788702000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 788702000.00
CCJ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 221248000.00
CCJ income_statement (quarterly, 2025-03-31) — Normalized Income: 79977600.00
CCJ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 110191000.00
CCJ cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 16925000.00
CCJ income_statement (quarterly, 2025-03-31) — Operating Income: 188028000.00
CCJ income_statement (quarterly, 2025-03-31) — Operating Revenue: 789432000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 435316918.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 164002000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 182835000.00
CCJ income_statement (quarterly, 2025-03-31) — Other Gand A: 58820000.00
CCJ income_statement (quarterly, 2025-03-31) — Other Income Expense: -38462000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Inventories: 1002000.00
CCJ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -34054000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 597059000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 338586000.00
CCJ income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 404000.00
CCJ income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 9307000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1174000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Payables: 346933000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 346933000.00
CCJ income_statement (quarterly, 2025-03-31) — Pretax Income: 123157000.00
CCJ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -56458000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Raw Materials: 152180000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Receivables: 185449000.00
CCJ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 519295000.00
CCJ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 60602000.00
CCJ cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -285841000.00
CCJ income_statement (quarterly, 2025-03-31) — Research And Development: 13982000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3168999000.00
CCJ cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CCJ cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 23000.00
CCJ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 58820000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Share Issued: 435316918.00
CCJ income_statement (quarterly, 2025-03-31) — Special Income Charges: -2217000.00
CCJ cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2068000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6491796000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6452659000.00
CCJ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1802400.00
CCJ income_statement (quarterly, 2025-03-31) — Tax Provision: 53405000.00
CCJ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CCJ balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 34930000.00
CCJ cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -51790000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Assets: 9384262000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 7487540000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Debt: 995744000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6491810000.00
CCJ income_statement (quarterly, 2025-03-31) — Total Expenses: 601404000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2892452000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7884137000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2337887000.00
CCJ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 185811000.00
CCJ income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 4625000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 704000.00
CCJ income_statement (quarterly, 2025-03-31) — Total Unusual Items: -12016000.00
CCJ income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12016000.00
CCJ balance_sheet (quarterly, 2025-03-31) — Working Capital: 945560000.00
CCJ income_statement (quarterly, 2025-06-30) — +Operating Expense: 91126000.00
CCJ income_statement (quarterly, 2025-06-30) — +Total Revenue: 877016000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 434871000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 291100000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 206553000.00
CCJ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 435331000.00
CCJ income_statement (quarterly, 2025-06-30) — Basic EPS: 0.74
CCJ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 361452000.00
CCJ cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -74923000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2936816000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 716292000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 716292000.00
CCJ cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
CCJ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -21456000.00
CCJ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -73936000.00
CCJ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 465200000.00
CCJ cash_flow (quarterly, 2025-06-30) — Change In Inventory: 162783000.00
CCJ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 88909000.00
CCJ cash_flow (quarterly, 2025-06-30) — Change In Receivables: -143926000.00
CCJ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 107766000.00
CCJ cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -143926000.00
CCJ cash_flow (quarterly, 2025-06-30) — Changes In Cash: 369808000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Common Stock: 2936816000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6741473000.00
CCJ cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1023000.00
CCJ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 619926000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Current Assets: 1801962000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 608894000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Current Provisions: 46044000.00
CCJ cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 71085000.00
CCJ cash_flow (quarterly, 2025-06-30) — Deferred Tax: 71085000.00
CCJ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 86472000.00
CCJ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 86472000.00
CCJ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 435331000.00
CCJ income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.74
CCJ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 320888000.00
CCJ cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 136970000.00
CCJ income_statement (quarterly, 2025-06-30) — EBIT: 414358000.00
CCJ income_statement (quarterly, 2025-06-30) — EBITDA: 500830000.00
CCJ income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 188421000.00
CCJ cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -188421000.00
CCJ cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -14968000.00
CCJ cash_flow (quarterly, 2025-06-30) — End Cash Position: 716292000.00
CCJ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -21456000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Finished Goods: 585651000.00
CCJ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 390277000.00
CCJ cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -163537000.00
CCJ income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -13000.00
CCJ income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 58786000.00
CCJ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 96436000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 37815000.00
CCJ income_statement (quarterly, 2025-06-30) — Gross Profit: 257090000.00
CCJ income_statement (quarterly, 2025-06-30) — Interest Expense: 22388000.00
CCJ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 22388000.00
CCJ income_statement (quarterly, 2025-06-30) — Interest Income: 5407000.00
CCJ income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5407000.00
CCJ cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -21368000.00
CCJ cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 5407000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Inventory: 734162000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7737438000.00
CCJ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -73936000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 3106734000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 243019000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 2863715000.00
CCJ cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1023000.00
CCJ cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CCJ balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
CCJ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 995965000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 995965000.00
CCJ cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CCJ cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1129000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 3106734000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 953737000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Minority Interest: 10000.00
CCJ income_statement (quarterly, 2025-06-30) — Minority Interests: 3000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1023000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Net Debt: 279673000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 88946000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income: 320888000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 320888000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 320885000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 320888000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 320888000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 320885000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 320885000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Interest Income: -21570000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1129000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1129000.00
CCJ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -21570000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 18000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 931000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Net PPE: 3260169000.00
CCJ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -74867000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6703658000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 715326000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 715326000.00
CCJ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 442057000.00
CCJ income_statement (quarterly, 2025-06-30) — Normalized Income: 272773669.55
CCJ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 465200000.00
CCJ cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -262999000.00
CCJ income_statement (quarterly, 2025-06-30) — Operating Income: 165964000.00
CCJ income_statement (quarterly, 2025-06-30) — Operating Revenue: 877016000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 435387448.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 127479000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 108216000.00
CCJ income_statement (quarterly, 2025-06-30) — Other Gand A: 96436000.00
CCJ income_statement (quarterly, 2025-06-30) — Other Income Expense: 247576000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Inventories: 984000.00
CCJ cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 16494000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 659550000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 281477000.00
CCJ income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 382000.00
CCJ income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -4602000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Other Receivables: 37057000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Payables: 435371000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 435371000.00
CCJ income_statement (quarterly, 2025-06-30) — Pretax Income: 391970000.00
CCJ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -74923000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Raw Materials: 147527000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Receivables: 351508000.00
CCJ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 619926000.00
CCJ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 86472000.00
CCJ cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1129000.00
CCJ income_statement (quarterly, 2025-06-30) — Research And Development: -708000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3489888000.00
CCJ cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 56000.00
CCJ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 96436000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Share Issued: 435387448.00
CCJ income_statement (quarterly, 2025-06-30) — Special Income Charges: -13000.00
CCJ cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2383000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6741473000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6703658000.00
CCJ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 10658669.55
CCJ income_statement (quarterly, 2025-06-30) — Tax Provision: 71085000.00
CCJ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.18
CCJ balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 23351000.00
CCJ cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -19263000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Assets: 9581556000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7737438000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Debt: 995965000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6741483000.00
CCJ income_statement (quarterly, 2025-06-30) — Total Expenses: 711052000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2840073000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 7779594000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2231179000.00
CCJ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 165951000.00
CCJ income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 4589000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 500000.00
CCJ income_statement (quarterly, 2025-06-30) — Total Unusual Items: 58773000.00
CCJ income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 58773000.00
CCJ balance_sheet (quarterly, 2025-06-30) — Working Capital: 1193068000.00
CCJ income_statement (quarterly, 2025-09-30) — +Operating Expense: 87739000.00
CCJ income_statement (quarterly, 2025-09-30) — +Total Revenue: 614555000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 402730000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 190898000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 208902000.00
CCJ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 435390000.00
CCJ income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CCJ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 716292000.00
CCJ cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -92510000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2937213000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 778651000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 778651000.00
CCJ cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
CCJ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4239000.00
CCJ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -93592000.00
CCJ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 155716000.00
CCJ cash_flow (quarterly, 2025-09-30) — Change In Inventory: -34807000.00
CCJ cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -47049000.00
CCJ cash_flow (quarterly, 2025-09-30) — Change In Receivables: 100380000.00
CCJ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 18524000.00
CCJ cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 100380000.00
CCJ cash_flow (quarterly, 2025-09-30) — Changes In Cash: 57885000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Common Stock: 2937213000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6780522000.00
CCJ cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 300000.00
CCJ income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 444305000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Current Assets: 1888357000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 631448000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Current Provisions: 44153000.00
CCJ cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 15867000.00
CCJ cash_flow (quarterly, 2025-09-30) — Deferred Tax: 15867000.00
CCJ cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 59108000.00
CCJ cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 59108000.00
CCJ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 435390000.00
CCJ income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CCJ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -141000.00
CCJ cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 0.00
CCJ income_statement (quarterly, 2025-09-30) — EBIT: 28694000.00
CCJ income_statement (quarterly, 2025-09-30) — EBITDA: 87802000.00
CCJ income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -16291000.00
CCJ cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 16291000.00
CCJ cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 4474000.00
CCJ cash_flow (quarterly, 2025-09-30) — End Cash Position: 778651000.00
CCJ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4239000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Finished Goods: 184625000.00
CCJ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 63206000.00
CCJ cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 66016000.00
CCJ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 204000.00
CCJ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -40119000.00
CCJ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 67499000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 37062000.00
CCJ income_statement (quarterly, 2025-09-30) — Gross Profit: 170250000.00
CCJ income_statement (quarterly, 2025-09-30) — Interest Expense: 12985000.00
CCJ income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 12985000.00
CCJ income_statement (quarterly, 2025-09-30) — Interest Income: 6807000.00
CCJ income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 6807000.00
CCJ cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -3911000.00
CCJ cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 6807000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Inventory: 899957000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7776678000.00
CCJ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -93592000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 3138341000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 253337000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 2885004000.00
CCJ cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 300000.00
CCJ cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CCJ balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
CCJ balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 996156000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 996156000.00
CCJ cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CCJ cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -628000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3138341000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 972640000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Minority Interest: 18000.00
CCJ income_statement (quarterly, 2025-09-30) — Minority Interests: 17000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 300000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Net Debt: 217505000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -29689000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income: -141000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -141000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -158000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -141000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -141000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -158000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -158000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Interest Income: -10926000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -628000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -628000.00
CCJ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -10926000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -1114000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Net PPE: 3313624000.00
CCJ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -92478000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6743460000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 700893000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 700893000.00
CCJ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 127717000.00
CCJ income_statement (quarterly, 2025-09-30) — Normalized Income: 33786750.00
CCJ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 155716000.00
CCJ cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 52414000.00
CCJ income_statement (quarterly, 2025-09-30) — Operating Income: 82511000.00
CCJ income_statement (quarterly, 2025-09-30) — Operating Revenue: 614555000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 435407158.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 179305000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 144661000.00
CCJ income_statement (quarterly, 2025-09-30) — Other Gand A: 67499000.00
CCJ income_statement (quarterly, 2025-09-30) — Other Income Expense: -55876000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Inventories: 991000.00
CCJ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 9499000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 661067000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 358560000.00
CCJ income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 330000.00
CCJ income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 9958000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7018000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Payables: 407990000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 407990000.00
CCJ income_statement (quarterly, 2025-09-30) — Pretax Income: 15709000.00
CCJ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -92510000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Raw Materials: 714341000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Receivables: 209749000.00
CCJ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 444305000.00
CCJ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 59108000.00
CCJ cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -628000.00
CCJ income_statement (quarterly, 2025-09-30) — Research And Development: 10282000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3489746000.00
CCJ cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 32000.00
CCJ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 67499000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Share Issued: 435407158.00
CCJ income_statement (quarterly, 2025-09-30) — Special Income Charges: 204000.00
CCJ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2446000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6780522000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6743460000.00
CCJ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -5987250.00
CCJ income_statement (quarterly, 2025-09-30) — Tax Provision: 15867000.00
CCJ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CCJ balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 11833000.00
CCJ cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -8791000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Assets: 9739344000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7776678000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Debt: 996156000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6780540000.00
CCJ income_statement (quarterly, 2025-09-30) — Total Expenses: 532044000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2958804000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7850987000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2327356000.00
CCJ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 93040000.00
CCJ income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 4748000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 5260000.00
CCJ income_statement (quarterly, 2025-09-30) — Total Unusual Items: -39915000.00
CCJ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -39915000.00
CCJ balance_sheet (quarterly, 2025-09-30) — Working Capital: 1256909000.00
CCJ income_statement (annual, 2025-12-31) — +Operating Expense: 349014000.00
CCJ income_statement (quarterly, 2025-12-31) — +Operating Expense: 68475000.00
CCJ income_statement (annual, 2025-12-31) — +Total Revenue: 3481933000.00
CCJ income_statement (quarterly, 2025-12-31) — +Total Revenue: 1200930000.00
CCJ balance_sheet (annual, 2025-12-31) — Accounts Payable: 190717000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 190717000.00
CCJ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 338426000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 338426000.00
CCJ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -6625796000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -6625796000.00
CCJ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 211412000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 211412000.00
CCJ income_statement (annual, 2025-12-31) — Basic Average Shares: 435362000.00
CCJ income_statement (annual, 2025-12-31) — Basic EPS: 1.35
CCJ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 600462000.00
CCJ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 778651000.00
CCJ cash_flow (annual, 2025-12-31) — Capital Expenditure: -333025000.00
CCJ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -109134000.00
CCJ balance_sheet (annual, 2025-12-31) — Capital Stock: 2938235000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2938235000.00
CCJ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1114860000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1114860000.00
CCJ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1214463000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1214463000.00
CCJ cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -104480000.00
CCJ cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -104480000.00
CCJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -442925000.00
CCJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -125570000.00
CCJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -433520000.00
CCJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -208603000.00
CCJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1408432000.00
CCJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 677325000.00
CCJ cash_flow (annual, 2025-12-31) — Change In Inventory: 20152000.00
CCJ cash_flow (quarterly, 2025-12-31) — Change In Inventory: -117981000.00
CCJ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 232137000.00
CCJ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 477903000.00
CCJ cash_flow (annual, 2025-12-31) — Change In Receivables: -15254000.00
CCJ cash_flow (quarterly, 2025-12-31) — Change In Receivables: -169024000.00
CCJ cash_flow (annual, 2025-12-31) — Change In Working Capital: 237035000.00
CCJ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 190898000.00
CCJ cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -15254000.00
CCJ cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -169024000.00
CCJ cash_flow (annual, 2025-12-31) — Changes In Cash: 531987000.00
CCJ cash_flow (quarterly, 2025-12-31) — Changes In Cash: 343152000.00
CCJ balance_sheet (annual, 2025-12-31) — Common Stock: 2938235000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Common Stock: 2938235000.00
CCJ cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -104480000.00
CCJ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6903363000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6903363000.00
CCJ cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2170000.00
CCJ cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 773000.00
CCJ balance_sheet (annual, 2025-12-31) — Construction In Progress: 355774000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 355774000.00
CCJ income_statement (annual, 2025-12-31) — Cost Of Revenue: 2511660000.00
CCJ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 928133000.00
CCJ balance_sheet (annual, 2025-12-31) — Current Assets: 2639215000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Current Assets: 2639215000.00
CCJ balance_sheet (annual, 2025-12-31) — Current Liabilities: 1070186000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1070186000.00
CCJ balance_sheet (annual, 2025-12-31) — Current Provisions: 47648000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Current Provisions: 47648000.00
CCJ cash_flow (annual, 2025-12-31) — Deferred Income Tax: 187719000.00
CCJ cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 47362000.00
CCJ cash_flow (annual, 2025-12-31) — Deferred Tax: 187719000.00
CCJ cash_flow (quarterly, 2025-12-31) — Deferred Tax: 47362000.00
CCJ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 293094000.00
CCJ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 86912000.00
CCJ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 293094000.00
CCJ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 86912000.00
CCJ income_statement (annual, 2025-12-31) — Diluted Average Shares: 435580000.00
CCJ income_statement (annual, 2025-12-31) — Diluted EPS: 1.35
CCJ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 589577000.00
CCJ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 199066000.00
CCJ cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 446749000.00
CCJ cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 240032000.00
CCJ balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 553584000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 553584000.00
CCJ income_statement (annual, 2025-12-31) — EBIT: 872980000.00
CCJ income_statement (quarterly, 2025-12-31) — EBIT: 300863000.00
CCJ income_statement (annual, 2025-12-31) — EBITDA: 1166074000.00
CCJ income_statement (quarterly, 2025-12-31) — EBITDA: 387775000.00
CCJ income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 216386000.00
CCJ income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 71107000.00
CCJ cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -216386000.00
CCJ cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -71107000.00
CCJ cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -17589000.00
CCJ cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -6943000.00
CCJ cash_flow (annual, 2025-12-31) — End Cash Position: 1114860000.00
CCJ cash_flow (quarterly, 2025-12-31) — End Cash Position: 1114860000.00
CCJ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -442925000.00
CCJ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -125570000.00
CCJ balance_sheet (annual, 2025-12-31) — Finished Goods: 181379000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Finished Goods: 181379000.00
CCJ cash_flow (annual, 2025-12-31) — Free Cash Flow: 1075407000.00
CCJ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 568191000.00
CCJ cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -145751000.00
CCJ cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -35217000.00
CCJ income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -3117000.00
CCJ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -1091000.00
CCJ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 33277000.00
CCJ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 24410000.00
CCJ income_statement (annual, 2025-12-31) — General And Administrative Expense: 311250000.00
CCJ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 88495000.00
CCJ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 36162000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 36162000.00
CCJ balance_sheet (annual, 2025-12-31) — Gross PPE: 9950873000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 9950873000.00
CCJ income_statement (annual, 2025-12-31) — Gross Profit: 970273000.00
CCJ income_statement (quarterly, 2025-12-31) — Gross Profit: 272797000.00
CCJ income_statement (annual, 2025-12-31) — Interest Expense: 95719000.00
CCJ income_statement (quarterly, 2025-12-31) — Interest Expense: 54438000.00
CCJ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 95719000.00
CCJ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 54438000.00
CCJ income_statement (annual, 2025-12-31) — Interest Income: 23172000.00
CCJ income_statement (quarterly, 2025-12-31) — Interest Income: 7269000.00
CCJ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 23172000.00
CCJ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7269000.00
CCJ cash_flow (annual, 2025-12-31) — Interest Paid Cff: -52642000.00
CCJ cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -21480000.00
CCJ cash_flow (annual, 2025-12-31) — Interest Received Cfo: 23172000.00
CCJ cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 7269000.00
CCJ balance_sheet (annual, 2025-12-31) — Inventory: 1013328000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Inventory: 1013328000.00
CCJ balance_sheet (annual, 2025-12-31) — Invested Capital: 7899711000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 7899711000.00
CCJ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -433520000.00
CCJ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -208603000.00
CCJ balance_sheet (annual, 2025-12-31) — Investments And Advances: 2987126000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2987126000.00
CCJ cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2170000.00
CCJ cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 773000.00
CCJ cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
CCJ cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CCJ balance_sheet (annual, 2025-12-31) — Land And Improvements: 5282968000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 5282968000.00
CCJ balance_sheet (annual, 2025-12-31) — Leases: 9478000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Leases: 9478000.00
CCJ balance_sheet (annual, 2025-12-31) — Long Term Debt: 996348000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 996348000.00
CCJ balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 996348000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 996348000.00
CCJ cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
CCJ cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CCJ cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -287973000.00
CCJ cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -375000.00
CCJ balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 2987126000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 2987126000.00
CCJ balance_sheet (annual, 2025-12-31) — Long Term Provisions: 953415000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 953415000.00